These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6644713)

  • 21. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)].
    Slobodina GA
    Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of combined chrisanol and balneological treatment on the clinical indicators and permeability of the synovian membrane in patients with rheumatoid arthritis].
    Taletene IP; Gaigalene BA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):28-31. PubMed ID: 6730385
    [No Abstract]   [Full Text] [Related]  

  • 23. Bronchoalveolar lavage and gold salt-induced pneumonitis.
    Breton JL; Garnier G; Toulouse J; Depierre A
    Chest; 1985 Mar; 87(3):410. PubMed ID: 3971774
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypogammaglobulinemia associated with gold therapy: evidence for a partial maturation blockade of B cells.
    Guillemin F; Bene MC; Aussedat R; Bannwarth B; Pourel J
    J Rheumatol; 1987 Oct; 14(5):1034-5. PubMed ID: 3501467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
    Malaise MG; Davin JC; Mahieu PR; Franchimont P
    Clin Immunol Immunopathol; 1986 Aug; 40(2):356-64. PubMed ID: 2941196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.
    Reychler R; De Geeter T; Verbruggen LA
    Clin Rheumatol; 1986 Jun; 5(2):275-7. PubMed ID: 3731724
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of combined drug treatment using gold preparations on indices of lipid peroxidation in patients with rheumatoid arthritis].
    Makarchuk OS
    Vrach Delo; 1990 Mar; (3):70-2. PubMed ID: 1973321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ambulatory treatment of rheumatoid arthritis with gold salts].
    Zborovskiĭ AB; Levshina AM
    Sov Med; 1990; (2):71-2. PubMed ID: 2356534
    [No Abstract]   [Full Text] [Related]  

  • 30. [Concentration of gold in macrophages of the bone marrow in rheumatic diseases subjected to chrysotherapy].
    Galle P; Villiaumey J
    Rev Rhum Mal Osteoartic; 1982 Mar; 49(4):273-9. PubMed ID: 7089467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [2 cases of fibrosing alveolitis in patients with rheumatoid arthritis treated with chrysanol].
    Repnitskaia ZD; Sunegin KB
    Klin Med (Mosk); 1990 Sep; 68(9):99-100. PubMed ID: 1981247
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gold-induced dermatitis (contact dermatitis and toxiderma)].
    Kalamkarian AA; Somov BA; Fedorov SM; Persina IS
    Vestn Dermatol Venerol; 1985 Aug; (8):4-8. PubMed ID: 2933891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the level of unsaturated fatty acids in rheumatoid arthritis patients during treatment].
    Berezhnitskiĭ MN; Virstiuk NG
    Vrach Delo; 1990 Dec; (12):23-5. PubMed ID: 1982475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nephrotic syndrome--rare complication of gold therapy].
    Klepikov PV; Nikolaev AIu; Varshavskiĭ VA; Pal'tsev MA; Androsova SO
    Ter Arkh; 1983; 55(10):98-101. PubMed ID: 6359555
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute colitis during treatment with gold salts].
    Manigand G; Dumont D; Faux N; Taillandier J; Gaultier T; Fritsch J; Szekely AM
    Presse Med; 1983 Oct; 12(34):2112-3. PubMed ID: 6226039
    [No Abstract]   [Full Text] [Related]  

  • 36. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 37. [Case of drug (krizanol) hepatitis].
    Korneĭchuk AV; Kushnir LV
    Vrach Delo; 1982 Feb; (2):41-2. PubMed ID: 7064450
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical notes about methylprednisolone pulse-therapy in patients with rheumatoid arthritis].
    Fomina LL
    Klin Med (Mosk); 1991 Mar; 69(3):72-5. PubMed ID: 1676774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complications of the treatment of rheumatoid arthritis with chrysanol].
    Gorokhovskaia GN; Kozhurin SV; Fedotenkov SA; Omel'ianenko NM; Kriuchkova LS
    Sov Med; 1989; (8):110-3. PubMed ID: 2573157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.